 | Up a level |
Spycher, M; Matozan, K; Minnig, K; Zehnder, R; Miescher, S; Hoefferer, L; Rieben, R (2009). In vitro comparison of the complement-scavenging capacity of different intravenous immunoglobulin preparations. Vox sanguinis, 97(4), pp. 348-54. Oxford: Wiley-Blackwell 10.1111/j.1423-0410.2009.01217.x
Banz, Yara; Gajanayake, Thusitha; Matozan, Katja; Yang, Zhihong; Rieben, Robert (2009). Dextran sulfate modulates MAP kinase signaling and reduces endothelial injury in a rat aortic clamping model. Journal of vascular surgery, 50(1), pp. 161-70. Amsterdam: Elsevier 10.1016/j.jvs.2009.01.067
Gajanayake, T; Sawitzki, B; Matozan, K; Korchagina, E Y; Lehmann, M; Volk, H-D; Rieben, R (2008). Dextran sulfate facilitates anti-CD4 mAb-induced long-term rat cardiac allograft survival after prolonged cold ischemia. American journal of transplantation, 8(6), pp. 1151-62. Oxford: Wiley-Blackwell 10.1111/j.1600-6143.2008.02239.x
Laumonier, Thomas; Walpen, Alexander J; Matozan, Katja M; Korchagina, Elena Y; Bovin, Nicolai V; Haeberli, André; Mohacsi, Paul J; Rieben, Robert (2004). Multimeric tyrosine sulfate acts as an endothelial cell protectant and prevents complement activation in xenotransplantation models. Xenotransplantation, 11(3), pp. 262-8. Hoboken, N.J.: Wiley 10.1111/j.1399-3089.2004.00125.x
Laumonier, Thomas; Mohacsi, Paul J; Matozan, Katja M; Banz, Yara; Haeberli, André; Korchagina, Elena Y; Bovin, Nicolai V; Vanhove, Bernard; Rieben, Robert (2004). Endothelial cell protection by dextran sulfate: a novel strategy to prevent acute vascular rejection in xenotransplantation. American journal of transplantation, 4(2), pp. 181-7. Oxford: Wiley-Blackwell 10.1046/j.1600-6143.2003.00306.x
